|
|
|
|
|
|
| Chairman and Chief Executive Officer Honored for Leadership and Success though Pivotal Year for Global Clinical Research Organization |
Raleigh, NC, Aug 2, 2012 - (ACN Newswire) - INC Research, LLC, a therapeutically focused clinical research organization (CRO) with a Trusted Process(R) for delivering reliable results, is pleased to announce Chairman and Chief Executive Officer James Ogle has been named to the annual PharmaVOICE 100 as one of the top driving forces in the life sciences industry. Under his leadership, INC Research acquired Kendle International, AVOS Consulting and Trident Clinical Research in a single calendar year, more than doubling the size of the Company. Despite the transformational nature of the acquisitions, INC Research successfully integrated operations while maintaining its focus on delivering the highest standards of quality and value to its customers.
Ogle has served as CEO of INC Research since 2003 and has more than two decades of experience in the CRO and biopharmaceutical industries. His outstanding leadership skills have been reflected in the transformation of INC Research into a top-tier global CRO, as demonstrated by the rapid and efficient completion of integration of three companies that greatly enhanced the Company's global profile in only 12 months.
During this same timeframe, the Company has continued to win awards for quality, consistency and delivery. In February, the 2012 CRO Quality Benchmarking Report from Industry Standard Research found INC Research had "the most consistent quality ratings of all of the companies we profiled, and their customers are very satisfied."
"The standards Jim sets and maintains for our global team ensure we follow through on our Trusted Process methodology to deliver consistent, repeatable results to the biopharmaceutical industry," said INC Research Chief Operating Officer Jamie Macdonald.
Known by his staff as a quick adopter, Ogle has stayed ahead of the curve with developments in technology. "Long before the metrics-driven dashboards common in the industry today, INC Research was collecting and analyzing metrics to help us improve delivery and customer satisfaction," said Senior Vice President, Corporate Development, Jean Chitwood. "That was all powered by Jim's view that the CRO industry is, at its heart, driven by strong project management."
Above all else, Ogle is recognized for his outstanding leadership skills, which have attributed to a cohesive team unit at INC Research. After completing a distinguished military career in which he achieved the rank of Lieutenant Colonel, United States Army, Ogle brought his timeless leadership approach to all facets of his profession. His staff is inspired by his ability to maintain the highest level of personal integrity and credibility, both of which have been driving forces behind the Company becoming an award-winning CRO.
"Jim uses strong emotional intelligence and surrounds himself with self-directed leaders that can absorb and follow his vision," explained INC Research Chief Information Officer Bill Pierce. "His big ideas and visions have matured and the result is a company that has moved into the top tier of our industry. Jim executes on what he believes, attracts the best and uses professionalism and innovation as the hallmark of how we serve our customers."
Featured in the July/August 2012 issue of PharmaVOICE, Ogle was selected from a group of nominations submitted by readers. A panel of PharmaVOICE editors evaluated the submissions based on the individual's ability to inspire, motivate and influence corporate leadership, research and development, technology, creativity, marketing, and strategy.
About PharmaVOICE
PharmaVOICE is expressly written and designed to deliver the views, opinions, and insights of executives who are shaping the direction of the dynamic life-sciences industry. PharmaVOICE reaches more than 17,500 readers every month in print and 70,000 with its digital edition.
PharmaVOICE's unique horizontal editorial approach cuts across industry silos, providing a holistic overview of the life-sciences industry, addressing a range of topics from molecule through market. By engaging compelling personalities from diverse industry sectors, PharmaVOICE provides multiple perspectives on business challenges, trends, and topics. Editorial content sparks dialog, initiates debate, and opens the lines of communication to facilitate and improve business-to-business relationships.
About INC Research
INC Research is a therapeutically focused clinical research organization with a high-performance reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase I through Phase IV programs in all therapeutic areas and innovative pediatric and women's health trials. The company's Trusted Process(R) methodology and therapeutic foresight lead customers to more confident, better-informed drug and device development decisions. INC Research is headquartered in Raleigh, NC. For more information, please visit www.incresearch.com or follow us at @inc_research.
Contact: Lori Dorer, Media +1-513-345-1685
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: INC RESEARCH, LLC via Thomson Reuters ONE
Topic: Press release summary
Source: INC Research, LLC
https://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
|
|
|
|
|
